Antibody Validations
Antibody Validations
About this Gateway
Antibodies are one of the most frequently used tools in any life sciences laboratory. Antibody validation is crucial to provide the information needed in order to reliably interpret the results of experiments. Validating an antibody is important work, and yet the results of these validations rarely get published. You can refer to our guidelines on preparing Antibody Validation Articles, and download the article template.
The Antibody Validations Gateway provides a platform where researchers and companies can both publish their antibody validation studies regardless of the outcome, and look up existing validation articles for antibodies of their interest. In this way, we hope to enhance the reliability and reproducibility of antibodies in scientific research.
Antibody validation articles cover a variety studies:
Read the Editorial by the Guest Editors for more details.
The Antibody Validations Gateway provides a platform where researchers and companies can both publish their antibody validation studies regardless of the outcome, and look up existing validation articles for antibodies of their interest. In this way, we hope to enhance the reliability and reproducibility of antibodies in scientific research.
Antibody validation articles cover a variety studies:
- New antibodies; either against a new target or a new antibody raised against an existing target.
- New applications for existing antibodies; either in a new biological system or a new application tested within an existing/previously tested biological system.
- Existing antibodies applied to a new biological system; new organism/tissue/cell type.
- Validations of previously tested antibodies that are carried out in more depth than before, in one or more applications.
- Validations of groups of antibodies raised against the same target.
- Antibodies that failed to meet the validation criteria.
- Replication studies that confirm or dispute previously published validations.
Read the Editorial by the Guest Editors for more details.
Gateway Advisors
-
Matt Helsby
CiteAb, UK -
Mei Leung
PeproTech EC Ltd, London, UK -
Andrew Chalmers
University of Bath, UK